Search clinical trials for: antiplatelet agent

Total 189850 results

Seoul National University Hospital
Seoul National University Bundang Hospital

Completed

Comparison of Two Different Antiplatelet Preparations for an Unruptured Intracranial Aneurysm

Aneurysm, Cerebral | Endovascular Procedures

Korea, Republic of
AstraZeneca

Completed

Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice (ALETHEIA)

Myocardial Infarction (MI)

Sweden, United Kingdom, United States, Italy, Germany
University of Edinburgh
NHS Lothian

Completed

Start or STop Anticoagulants Randomised Trial (SoSTART) (SoSTART)

Atrial Fibrillation | Intracranial Hemorrhages | Subarachnoid Hemorrhage | Intraventricular Hemorrhage | Atrial Flutter | Small Vessel Cerebrovascular Disease | Intracranial Hemorrhage, Hypertensive | Subdural Hematoma | Microhaemorrhage

United Kingdom
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Mild Head Injury, Antiplatelets, and Anticoagulants

Craniocerebral Trauma | Cerebral Hemorrhage

Italy
Ukrainian Medical Stomatological Academy

Completed

Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease (EFFORT)

Adverse Effect | Atherosclerosis, Coronary | Insulin Resistance Syndrome

Ukraine
Andres Iñiguez Romo

Completed

Platelet REACtivity According to TICagrelor Dose After Transcatheter AorticValve Implantation (REACTIC-TAVI)

Symptomatic Aortic Stenosis

Spain
Organon and Co

Completed

Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(P05926)(COMPLETED)

Schizophrenia
University Hospital, Bordeaux

Completed

Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study. (GASTRIM)

Impairment of Gastric Emptying | Acute Phase of Myocardial Infarction

France
University Hospital, Bordeaux

Completed

Safety Profile Evaluation of TICagrelor Alone Compared to a Combination of Lysine Acetylsalicylate-Clopidogrel in the Context of Transcatheter Aortic Valve Implantation (TAVI) (TICTAVI)

Aortic Valve Stenosis

France
Shanghai 10th People's Hospital

Completed

Ankle Brachial Index Combined With Serum Uric Acid Levels Improve Prediction All Cause Mortality and Cardiovascular Mortality in the Elderly Chinese Population (abilities)

Ankle Brachial Index
Assistance Publique - Hôpitaux de Paris
Bayer; Action Research Group

Completed

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure (ADRIFT)

Hemorrhage | Atrial Fibrillation | Atrial Appendage

France
Mayo Clinic
National Heart, Lung, and Blood Institute (NHLBI); Spartan Bioscience Inc.; Applied...

Completed

Tailored Antiplatelet Therapy Following PCI (TAILOR-PCI)

Coronary Artery Disease | Acute Coronary Syndrome | Stenosis

United States, Korea, Republic of, Canada, Mexico
Bloodworks
United States Department of Defense

Active, not recruiting

Reversal of Aspirin Antiplatelet Therapy With Cold Stored Platelets (RASP)

Reversal of Platelet Aggregation Inhibitors

United States
Duk-Woo Park, MD
CardioVascular Research Foundation, Korea; Daiichi Sankyo Korea Co., Ltd.

Completed

Anticoagulant Versus Dual Antiplatelet Therapy for Preventing Leaflet Thrombosis and Cerebral Embolization After Transcatheter Aortic Valve Replacement (ADAPT-TAVR)

Aortic Valve Stenosis

Taiwan, Hong Kong, Korea, Republic of
Abbott Medical Devices

Completed

XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.

Coronary Artery Lesions

United States
Associacao para Investigacao e Desenvolvimento...
AstraZeneca; Cardiovascular Centre of the University of Lisbon (CCUL)

Active, not recruiting

Anti-thrombotic and Glucose Lowering Therapy in Diabetic Patients Undergoing PCI (ARTHEMIS)

Coronary Heart Disease | Type2 Diabetes Mellitus

Portugal
Bristol-Myers Squibb

Completed

A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects

Healthy Volunteers

United States
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

The Antiplatelet and Immune Response Trial

Healthy

United Kingdom
Bayer
Janssen Research & Development, LLC

Completed

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (UK)

Venous Thrombosis | Atrial Fibrillation | Acute Coronary Syndrome | Pulmonary Embolism

United Kingdom
Acticor Biotech

Completed

Glenzocimab in SARS-Cov-2 Acute Respiratory DistrEss syNdrome Related to COVID-19 (GARDEN)

COVID-19 | Acute Respiratory Distress Syndrome | ARDS | SARS-CoV Infection

France
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Attikon Hospital
Hellenic Cardiology Society

Completed

The Greek AntiPlatElet Atrial Fibrillation Registry. (GRAPE-AF)

Coronary Artery Disease | Atrial Fibrillation

Greece
Ottawa Heart Institute Research Corporation
Bristol-Myers Squibb; Sanofi

Completed

Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial) (CASCADE)

Atherosclerosis

Canada
Ya-Wei Xu

Completed

Epidemic Profile of Left Ventricular Diastoic Dysfunction in the Community Elderly and Establishing Prediction Model: the Northern Shanghai Study (ELITISM)

Left Ventricular Diastoic Dysfunction Cohort Study
Seoul National University Hospital
Chong Kun Dang Pharmaceutical; Daewoong Pharmaceutical Co. LTD.; Hanmi Pharmaceutical... and other collaborators

Completed

Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)

Coronary Heart Disease

Korea, Republic of
Julio Ramirez
University of Louisville

Terminated

Patients Response to Early Switch To Oral:Osteomyelitis Study (PRESTO:Osteo)

Osteomyelitis

United States
The Catholic University of Korea
Chonnam National University Hospital

Completed

TicAgrelor Versus CLOpidogrel in Stabilized Patients With Acute Myocardial Infarction: TALOS-AMI

Acute Myocardial Infarction

Korea, Republic of
Shanghai 10th People's Hospital

Completed

A Prospective Cohort Study of China Serum Uric Acid Levels (ASSURE)

Uric Acid Serum
Abbott Medical Devices

Completed

XIENCE 28 Global Study

Coronary Artery Disease | Renal Insufficiency | Anemia | Thrombocytopenia | Coagulation Disorder | Stroke, Ischemic | Stroke Hemorrhagic | Bleeding Disorder | Hematological Disease

China, Spain, Belgium, Germany, Portugal, Switzerland, Hong Kong, United Kingdom, Austria, Italy, Netherlands, Singapore, Taiwan
Assistance Publique - Hôpitaux de Paris
Action Research Group; Bristol-Meyers Squibb & Pfizer

Completed

Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis (ATLANTIS)

Symptomatic Aortic Stenosis | Eligible for Transcatheter Aortic Valve Replacement

France, Germany, Italy, Spain
University of Texas Southwestern Medical Center

Completed

Antiplatelet Strategy for Peripheral Arterial Interventions for Revascularization of Lower Extremities (ASPIRE)

Peripheral Arterial Disease

United States
Biosensors Europe SA

Active, not recruiting

LEADERS FREE II: BioFreedom™ Pivotal Study

Acute Coronary Syndrome | High Bleeding Risk

United States, Canada, France, Italy, United Kingdom, Germany, Denmark
Karolinska Institutet

Completed

HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study (HELPpilot)

NSTEMI - Non-ST Segment Elevation MI | STEMI - ST Elevation Myocardial Infarction

Sweden
Medical University of Warsaw
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Completed

Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial Infarction (AFFECT EV)

Myocardial Infarction

Netherlands, Poland
Dong-A University

Unknown

3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI (BULK-STEMI)

ST Elevation Myocardial Infarction

Korea, Republic of
W.L.Gore & Associates

Completed

GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients (REDUCE)

Stroke | Transient Ischemic Attack

United States, Denmark
Scripps Health
Medtronic

Completed

Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) (SEASIDE)

Coronary Artery Disease | Coronary Thrombosis

United States
Shenyang Northern Hospital

Unknown

Optimal antiPlatelet Therapy for High Bleeding and Ischemic RISK Patients Trial (OPT-BIRISK)

Prolonged DAPT in ACS Patients With Hisk of Both Ischemic and Hemorrhage

China
Boston Scientific Corporation

Completed

EVOLVE Short DAPT Study

Coronary Artery Disease

United States, Germany, Latvia, Japan, Sweden, Brazil, Switzerland
Nanjing Medical University

Unknown

Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage

Aneurysmal Subarachnoid Hemorrhage

China
Beijing Neurosurgical Institute

Completed

Application of Platelet Function Test in Prevention of Ischemic Events After Stent Placement in Intracranial Aneurysms (APISIA Trail)

Stents | Unruptured Intracranial Aneurysm | Antiplatelet Drugs

China
Korea University Guro Hospital

Terminated

Antithrombotic Treatment in Patients With Effectively Maintained Sinus Rhythm After Atrial Fibrillation Ablation (ATEMS-AF)

Atrial Fibrillation

Korea, Republic of
The First Affiliated Hospital with Nanjing Medical...

Unknown

OPTImal Management of Antithrombotic Agents: OPTIMA-5

Acute Coronary Syndrome (ACS)

China
Fundació Institut de Recerca de l'Hospital de la...

Completed

Evolution of COVID-19 in Anticoagulated or Antiaggregated Patients (CORONA Study) (CORONA)

Covid19

Spain
University Hospital Inselspital, Berne
European Cardiovascular Research Center

Completed

GLOBAL LEADERS Adjudication Sub-Study (GLASSY)

Coronary Artery Disease | Platelet-aggregation Inhibitors

Bulgaria, Switzerland, Austria, Belgium, Germany, Italy, Netherlands, Poland, United Kingdom
Faculty Hospital Kralovske Vinohrady

Completed

The Laboratory AntiPlatelet Efficacy and Clinical Outcome Registry (LAPCOR)

Platelet Aggregation Onhibitors

Czechia
General Hospital of Shenyang Military Region

Completed

Argatroban Combined With Antiplatelet Versus Antiplatelet for Acute Ischemic Stroke

Stroke, Ischemic

China
Fundación Pública Andaluza para la gestión de la...
Spanish Network for Research in Infectious Diseases

Completed

Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae (SIMPLIFY)

Enterobacteriaceae Infections

Spain
LMU Klinikum

Terminated

Comparison of Loading Strategies With Antiplatelet Drugs in Patients Undergoing Elective Coronary Intervention (SASSICAIA)

Angina Pectoris

Germany, Hungary
Bloodworks
National Blood Foundation

Unknown

Reversal of Dual Antiplatelet Therapy With Cold Stored Platelets (R-DAPT)

Bleeding | Platelet Dysfunction Due to Drugs | Platelet Dysfunction

United States

Search clinical trials for: antiplatelet agent

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations